机译:关于银屑病关节炎和潜在治疗目标发病机制的最新特征
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Univ Federico II Sch Med &
Surg Dept Clin Med &
Surg Rheumatol Unit Naples Italy;
Sapienza Univ Rome Dept Internal Med &
Med Specialties Arthrit Ctr Rome Italy;
Univ Federico II Sch Med &
Surg Dept Clin Med &
Surg Rheumatol Unit Naples Italy;
Univ Roma Tor Vergata Dept Syst Med Rheumatol Allergol &
Clin Immunol Rome Italy;
Psoriatic arthritis; innate immunity; bone remodeling; target therapies;
机译:关于银屑病关节炎和潜在治疗目标发病机制的最新特征
机译:IL-33在类风湿关节炎中的治疗潜力:评论Talabot-Ayer D等人的文章“类风湿关节炎,银屑病关节炎和骨关节炎中血清和滑液白介素(IL)-33的水平不同”,关节骨脊柱2012; 79:32-7
机译:在帕金森病中富含亮氨酸的重复激酶2:从发病机制到潜在的治疗目标
机译:更新类风湿性关节炎的发病机制
机译:TRP通道在类风湿性关节炎滑膜纤维细胞靶向中的治疗潜力
机译:t(8; 21)(q22; q22.1); RUNX1-RUNX1T1对AML的分子发病机制和潜在治疗靶点的更新
机译:牛皮癣和银屑病关节炎患者的血管生成:细胞介导和体液机制,其在发病机制中的作用,以及寻找有前途的治疗目标